Centene Corp (CNC)

Return on total capital

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Earnings before interest and tax (EBIT) US$ in thousands 4,959,000 2,930,000 2,627,000 2,478,000 3,501,000
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 26,410,000 25,840,000 24,057,000 26,795,000 25,773,000
Return on total capital 18.78% 11.34% 10.92% 9.25% 13.58%

December 31, 2024 calculation

Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $4,959,000K ÷ ($—K + $26,410,000K)
= 18.78%

Centene Corp's return on total capital has shown variations over the past five years. In December 2020, the return on total capital was 13.58%, indicating a solid performance. However, by December 2021, the return decreased to 9.25%, suggesting a dip in the company's efficiency in generating returns from its total capital.

Subsequently, in December 2022 and 2023, the return on total capital improved to 10.92% and 11.34% respectively, indicating a recovery in performance. Notably, by December 2024, the return on total capital surged to 18.78%, reflecting significant improvement and potentially efficient utilization of capital resources.

Overall, Centene Corp's return on total capital has shown fluctuations but ended on a strong note in 2024, which could be a positive signal for investors and stakeholders. It is essential for the company to maintain steady growth in this metric to ensure sustainable performance and value creation in the future.


Peer comparison

Dec 31, 2024

Company name
Symbol
Return on total capital
Centene Corp
CNC
18.78%
Cigna Corp
CI
16.34%
Humana Inc
HUM
15.65%
Molina Healthcare Inc
MOH
23.01%